Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jan
5
2023
 Foods Produced from Animal Cells: What’s in a Name? Keller and Heckman LLP
Jan
5
2023
 Sesame Listed as Major Food Allergen Keller and Heckman LLP
Jan
5
2023
 ANDA Filing Alone Insufficient for Induced Infringement of Method Patent McDermott Will & Emery
Jan
5
2023
 If You Don’t Believe, You Won’t Receive: Predicting Three Cannabis Reforms in the Coming Year Bradley Arant Boult Cummings LLP
Jan
4
2023
 Petition Filed to Add Polyphenylene Sulfide to List of Chemical Substances Subject to Superfund Excise Tax Bergeson & Campbell, P.C.
Jan
4
2023
 IDR Payment Disputes are Far Outpacing Projections, Creating Backlogs Squire Patton Boggs (US) LLP
Jan
4
2023
 California Judge Temporarily Enjoins Implementation of FAST Recovery Act Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
4
2023
 Target’s Fruit Punch Water Enhancer Class Action Permanently Dismissed Keller and Heckman LLP
Jan
3
2023
 Cosmetic Regulatory Reform Finally Becomes Law Mintz
Jan
3
2023
 2022, Who Were You? A Recap of Hot Issues in 2022. Bradley Arant Boult Cummings LLP
Jan
3
2023
 FDA Releases 2022 Edition of the Food Code Keller and Heckman LLP
Jan
3
2023
 A Way Too Early Prediction: Alabama Cannabis 2.0 Bradley Arant Boult Cummings LLP
Dec
31
2022
 China to Remove Infringing Pharmaceuticals from Procurement Platforms Schwegman, Lundberg & Woessner, P.A.
Dec
30
2022
 Potential Litigation Impacts of the Modernization of Cosmetics Regulation Act of 2022 Greenberg Traurig, LLP
Dec
30
2022
 Companies Gear Up For Mass Production of Cultured Meat Womble Bond Dickinson (US) LLP
Dec
30
2022
 New Cosmetic Regulatory Requirements: What Cosmetic Manufacturers Need to Know Greenberg Traurig, LLP
Dec
29
2022
 Mississippi Medical Cannabis, Charles Dickens Style Bradley Arant Boult Cummings LLP
Dec
29
2022
 Welcome (but Last Minute) Relief for Prescription Drug Reporting Originally Due December 27 McDermott Will & Emery
Dec
29
2022
 Petition Filed to Add Polyoxymethylene to List of Chemical Substances Subject to Superfund Excise Tax Bergeson & Campbell, P.C.
Dec
29
2022
 Doctor-Patient Relationships and Medical Marijuana: Where Are We Now?
Dec
28
2022
 EPA Finds Carbon Tetrachloride, as a Whole Chemical Substance, Poses an Unreasonable Risk to Human Health Bergeson & Campbell, P.C.
Dec
28
2022
 Consolidated Appropriations Act, 2023 Contains Significant Provisions for Cosmetic Products ArentFox Schiff LLP
Dec
28
2022
 RxDC Reporting Relief for Plans, Issuers, and Plan Service Providers Foley & Lardner LLP
Dec
28
2022
 Federal Regulators Offer Employer Health Plans Last-Minute Relief on Prescription Drug Reporting Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
27
2022
 EPA Announces Removal of PFAS Chemicals from Approved Inert Ingredient List for Pesticide Products Bergeson & Campbell, P.C.
Dec
27
2022
 FDA Expands Inspection Guidance to Apply to Device Manufacturers Sheppard, Mullin, Richter & Hampton LLP
Dec
24
2022
 Back to the Drawing Board: CMS Proposes Changing the Overpayment Rule’s “Identified” Definition McDermott Will & Emery
Dec
24
2022
 The Greatest Gift of All…Tri-Agencies Issue Welcome Relief on Prescription Drug Reporting Proskauer Rose LLP
Displaying 2577 - 2604 of 12182
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters